DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

LinksClose Window

References

Motzer RJ, Tannier NM, McDermott DF. et al.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma. (akzeptiert für NEJM).

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.